Avricore Health (AVCRF) Cash from Operations Growth (1y) (2015 - 2026)
Avricore Health (AVCRF) Cash from Operations Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 14.65% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 86.90% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 25.96% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -9.63% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 31.33% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 9.74% |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.13% |
| Sep 30, 2025 | -145.84% |
| Jun 30, 2025 | -195.76% |
| Mar 31, 2025 | -49.25% |
| Sep 30, 2024 | 251.42% |
| Jun 30, 2024 | 205.54% |
| Mar 31, 2024 | 339.24% |
| Dec 31, 2023 | 1,118.76% |
| Sep 30, 2023 | 805.89% |
| Jun 30, 2023 | 153.78% |
| Mar 31, 2023 | 144.57% |
| Dec 31, 2022 | 91.78% |
| Sep 30, 2022 | 105.90% |
| Jun 30, 2022 | 33.19% |
| Mar 31, 2022 | 33.18% |
| Dec 31, 2021 | 19.61% |
| Sep 30, 2021 | -90.45% |
| Jun 30, 2021 | -49.85% |
| Mar 31, 2021 | 28.42% |
| Dec 31, 2020 | -532.14% |